The PE Ratio as of July 2024 (TTM) for AbCellera Biologics Inc. (ABCL) is -6.39

According to AbCellera Biologics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.39. This represents a change of -41.51% compared to the average of -10.93 of the last 4 quarters.

AbCellera Biologics Inc. (ABCL) Historical PE Ratio (quarterly & annually)

How has ABCL PE Ratio performed in the past?

The mean historical PE Ratio of AbCellera Biologics Inc. over the last ten years is 5.96K. The current -6.39 PE Ratio has changed -110.73% with respect to the historical average. Over the past ten years (40 quarters), ABCL's PE Ratio was at its highest in in the June 2020 quarter at 473.22. The PE Ratio was at its lowest in in the December 2019 quarter at -1932.99.

AbCellera Biologics Inc. (ABCL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AbCellera Biologics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AbCellera Biologics Inc. (ABCL) Average PE Ratio

How has ABCL PE Ratio performed in the past?

The current PE Ratio of AbCellera Biologics Inc. (ABCL) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

AbCellera Biologics Inc. (ABCL) PE Ratio vs. Peers

How is ABCL’s PE Ratio compared to its peers?

AbCellera Biologics Inc.’s PE Ratio is less than CohBar, Inc. (-0.12), less than Hepion Pharmaceuticals, Inc. (-0.10), less than Rain Therapeutics Inc. (-0.62), less than Krystal Biotech, Inc. (105.76), less than AVROBIO, Inc. (2.07), less than CureVac N.V. (-2.83), greater than Reata Pharmaceuticals, Inc. (-89.36), less than Vir Biotechnology, Inc. (-2.68), less than Propanc Biopharma, Inc. (-0.02), less than PTC Therapeutics, Inc. (-4.50), less than Sarepta Therapeutics, Inc. (802.35), less than Iovance Biotherapeutics, Inc. (-5.48), greater than Madrigal Pharmaceuticals, Inc. (-12.81),

Build a custom stock screener for AbCellera Biologics Inc. (ABCL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbCellera Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbCellera Biologics Inc. (ABCL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbCellera Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.